Anti-apoptotic activity of low levels of wild-type p53

EMBO Journal

Volumn 15, Issue 17, 1996, Pages 4566-4573

  Lassus, Patrice ^a   Ferlin, Martine ^a   Piette, Jacques ^a   Hibner, Urszula ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Apoptosis; Cell cycle; Oncogenesis; p53

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL IMMORTALIZATION; FIBROBLAST; MOUSE; NONHUMAN; ONCOGENE; PHYSIOLOGY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029814061     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00834.x     Document Type: Article

References (40)

1. Bissonnette, R.P., Echeveri, F., Mahboubi, A. and Green, D.R. (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature, 359, 552-554.
2. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53 target genes. Nature, 370, 220-223.
3. Canman, C., Gilmer, T.A., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
4. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
5. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr, Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221.
6. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
7. Fanidi, A., Harrington, E.A. and Evan, G.I. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature, 359, 554-556.
8. Fujiwara, T., Grimm, E.A., Mukhopadhyay, T., Wei Cai, D., Owen-Schaub, L.B. and Roth, J.A. (1993) A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53, 4129-4133.
9. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501.
10. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
11. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature, 379, 88-91.
12. Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5, 84-90.
13. Harrington, E.A., Bennett, M.R., Fanidi, A. and Evan, G.I. (1994) c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13, 3286-3295.
14. Harris, C.C. (1993) p53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-1981.
15. Harvey, D. and Levine, A.J. (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5, 2375-2385.
16. Hermeking, H. and Eick, D. (1994) Mediation by p53 of apoptosis induced by c-myc. Science, 265, 2091-2093.
17. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
18. Jacks, T., Remington, L., Williams, B., Scmitt, E., Halachmi, S., Bronson, R. and Weinberg, R. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
19. Jones, S.N., Roe, A.E., Donehower, L.A. and Bradley, A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature, 378, 206-208.
20. Leroy-Viard, K., Vinit, M.-A., Lecointe, N., Jouault, H., Hibner, U., Roméo, P.-H. and Mathieu-Mahul, D. (1995) Loss of Tal-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J., 14, 2341-2349.
21. Lotem, J. and Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
22. Lowe, S.C., Scmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993a) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
23. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D. (1993b) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
24. Malcomson, R.D.G., Oren, M., Wyllie, A.H. and Harisson, D.J. (1995) p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br. J. Cancer, 72, 952-957.
25. Metz, T., Harris, A.W. and Adams, J.M. (1995) Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell, 82, 29-36.
26. Michalovitz, D., Halevy, O. and Oren, M. (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671-680.
27. Montes de Oca Luna, R., Wagner, D.S. and Lozano, G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 378, 203-206.
28. Olson, D.C., Marechal, V., Momand, J., Chen, J., Romocki, C. and Levine, A.J. (1993) Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene, 8, 2353-2360.
29. Raff, M.C. (1992) Social controls on cell survival and cell death. Nature, 356, 397-400.
30. Sah, V.P., Attardi, L.D., Mulligan, G.J., Williams, B.O., Bronson, R.T. and Jacks, T. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nature Genet., 10, 175-179.
31. Schmid, P., Lorenz, A., Hameister, H. and Montenarh, M. (1991) Expression of p53 during mouse embryogenesis. Development, 113, 857-865.
32. Sehgal, P.B. and Margulies, L. (1993) Cell-type- and promoter-dependent ts phenotype of p53 Val135. Oncogene, 8, 3417-3419.
33. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B. and Costa, J. (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl Acad. Sci. USA, 89, 4495-4499.
34. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T. and Van Dyke, T. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703-711.
35. Wagner, A.J., Small, M.B. and Hay, N. (1993) Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol. Cell. Biol., 13, 2432-2440.
36. waf1/cip1. Genes Dev., 8, 2817-2830.
37. Wahl, A.F., Donaldson, K.L., Fairchild, C., Lee, F.Y.F., Foster, S.A., Demers, G.W. and Galloway, D.A. (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis Nature Med., 2, 72-79.
38. Wu, X., Bayle, H., Olson, D. and Levine, A. (1993) The p53-mdm2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132.
39. Yonish-Rouach, D., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 protein induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
40. Yonish-Rouach, E., Borde, J., Gotteland, M., Mishal, Z., Viron, A. and May, E. (1994) Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. Cell Death Differ., 1, 39-49.